Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

145 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
Ladabaum U, Mannalithara A. Ladabaum U, et al. Gastroenterology. 2016 Sep;151(3):427-439.e6. doi: 10.1053/j.gastro.2016.06.003. Epub 2016 Jun 14. Gastroenterology. 2016. PMID: 27311556
Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.
Ladabaum U, Chopra CL, Huang G, Scheiman JM, Chernew ME, Fendrick AM. Ladabaum U, et al. Ann Intern Med. 2001 Nov 6;135(9):769-81. doi: 10.7326/0003-4819-135-9-200111060-00007. Ann Intern Med. 2001. PMID: 11694102
Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
Ladabaum U, Chey WD, Scheiman JM, Fendrick AM. Ladabaum U, et al. Aliment Pharmacol Ther. 2002 Aug;16(8):1491-501. doi: 10.1046/j.1365-2036.2002.01306.x. Aliment Pharmacol Ther. 2002. PMID: 12182749
Safety, efficacy and costs of pharmacotherapy for functional gastrointestinal disorders: the case of alosetron and its implications.
Ladabaum U. Ladabaum U. Aliment Pharmacol Ther. 2003 Apr;17(8):1021-30. doi: 10.1046/j.1365-2036.2003.01545.x. Aliment Pharmacol Ther. 2003. PMID: 12694084
Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis.
Ladabaum U, Scheiman JM, Fendrick AM. Ladabaum U, et al. Am J Med. 2003 May;114(7):546-54. doi: 10.1016/s0002-9343(03)00095-0. Am J Med. 2003. PMID: 12753878
Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.
Song K, Fendrick AM, Ladabaum U. Song K, et al. Among authors: ladabaum u. Gastroenterology. 2004 May;126(5):1270-9. doi: 10.1053/j.gastro.2004.02.016. Gastroenterology. 2004. PMID: 15131787
Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis.
Mein SM, Ladabaum U. Mein SM, et al. Among authors: ladabaum u. Aliment Pharmacol Ther. 2004 Jun 1;19(11):1199-210. doi: 10.1111/j.1365-2036.2004.01958.x. Aliment Pharmacol Ther. 2004. PMID: 15153173
Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact?
Ladabaum U, Song K, Fendrick AM. Ladabaum U, et al. Clin Gastroenterol Hepatol. 2004 Jul;2(7):554-63. doi: 10.1016/s1542-3565(04)00247-2. Clin Gastroenterol Hepatol. 2004. PMID: 15224279
Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.
Patel D, Terrault NA, Yao FY, Bass NM, Ladabaum U. Patel D, et al. Among authors: ladabaum u. Clin Gastroenterol Hepatol. 2005 Jan;3(1):75-84. doi: 10.1016/s1542-3565(04)00443-4. Clin Gastroenterol Hepatol. 2005. PMID: 15645408
Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand.
Ladabaum U, Song K. Ladabaum U, et al. Gastroenterology. 2005 Oct;129(4):1151-62. doi: 10.1053/j.gastro.2005.07.059. Gastroenterology. 2005. PMID: 16230069
145 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page